A heparin–rosuvastatin-loaded P(LLA-CL) nanofiber-covered stent inhibits inflammatory smooth-muscle cell viability to reduce in-stent stenosis and thrombosis

BACKGROUND: An endovascular covered-stent has unique advantages in treating complex intracranial aneurysms; however, in-stent stenosis and late thrombosis have become the main factors affecting the efficacy of covered-stent treatment. Smooth-muscle-cell phenotypic modulation plays an important role...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yingjun, Liu, Peixi, Song, Yaying, Li, Sichen, Shi, Yuan, Quan, Kai, Yu, Guo, Li, Peiliang, An, Qingzhu, Zhu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086342/
https://www.ncbi.nlm.nih.gov/pubmed/33926468
http://dx.doi.org/10.1186/s12951-021-00867-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086342/
https://www.ncbi.nlm.nih.gov/pubmed/33926468
http://dx.doi.org/10.1186/s12951-021-00867-8

Ejemplares similares